Minxiang Xie
Key Laboratory Of Medical Molecular Virology
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Receptor-mimicking antibodies retain neutralization of recent SARS-CoV-2 variants.
Journal: Biosafety and health
Published: April 29, 2026
Potent in vitro synergistic antiviral effects of the pan-coronavirus fusion inhibitor EK1 in combination with RBD-specific antibodies or Mpro inhibitors.
Journal: Journal of virology
Published: March 30, 2026
Anti-S2 antibodies responsible for the SARS-CoV-2 infection-induced serological cross-reactivity against MERS-CoV and MERS-related coronaviruses.
Journal: Frontiers in immunology
Published: December 07, 2024
Fortuitous Somatic Mutations during Antibody Evolution Endow Broad Neutralization against SARS-CoV-2 Omicron Variants.
Journal: bioRxiv : the preprint server for biology
Published: December 23, 2022
Interleukin-35 -producing B cells rescues inflammatory bowel disease in a mouse model via STAT3 phosphorylation and intestinal microbiota modification.
Journal: Cell death discovery
Published: December 11, 2022
Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history.
Journal: BMC biology
Published: December 11, 2022
Characterization of cross-reactive monoclonal antibodies against SARS-CoV-1 and SARS-CoV-2: Implication for rational design and development of pan-sarbecovirus vaccines and neutralizing antibodies.
Journal: Journal of medical virology
Published: November 10, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026